EUCTR2021-000592-36-DE招募中1 期
Calcitonin Gene-Related Peptide Receptor Antagonists for Prevention of Acute Mountain Sickness
niversitätsklinikum Essen0 个研究点目标入组 30 人开始时间: 2023年1月13日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •- Age 18-60 years
- •- Good physical condition
- •- No relevant pathologies revealed upon the pre-examination prior to the study
- •- Written informed consent to participate in the study
- •- Permanent residency below 1000 m
- •- Males and females are included without prioritization
- •- More than 3 weeks since vaccination against or full recovery from SARS-CoV2 infection
- •- Negative serum or urine pregnancy test in women of childbearing potential if pregnancy cannot be ruled out
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 30
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
排除标准
- •- Intolerance against erenuma or any drug component
- •- Acute and chronic lung diseases
- •- Cardiovascular diseases other than hypertension (coronary heart disease, heart failure, atrial fibrillation, peripheral artery disease)
- •- Conventional systolic blood pressure =150 mmHg and conventional diastolic blood pressure =95 mmHg (average of two measurements) in untreated or treated subjects
- •- Chronic headache / migraine
- •- Diabetes mellitus
- •- Smoking (>6 cigarettes/day) or equivalent nicotine substitutes
- •- Alcohol (>30 g/d) or drug abuse
- •- Obesity (Body Mass Index >30)
- •- Other conditions deemed relevant by the investigator (including liver disease, renal disease, thyroid disorders, Parkinson disease, pheochromocytoma)
- •- Sojourn >2000 m within the last 8 weeks before the 1st study day
- •- Drug intake within the last 2 moth before the 1st study day if the drug intake could affect the data quality (eg. corticosteroids) or the safety of the participants (eg. anti-coagulants)
- •- Blood donation within the last 2 month before the 1st study day
- •- Pregnant or nursing women
- •- Participation in other clinical trials
研究者
相似试验
招募中
不适用
Detection of Calcitonin Gene-related Peptide (CGRP) in perilymph of patients with Menière’s DiseaseMénière diseaseDRKS00031208MU Klinik, Universitätsklinikum der Ludwig Maximilians Universität München40
已完成
不适用
Calcitonin Gene-Related Peptide (CGRP) in patients with migraine and endometriosisG43.0N80.9Migraine without aura [common migraine]Endometriosis, unspecifiedDRKS00020744Charité Campus Charité Mitte125
招募中
不适用
Detection of calcitonin gene-related peptide (CGRP) in serum and tear fluid in headache associated with changes in CSF pressure or sinus vein thrombosis.G93.2I67.6G97.1G44.8Nonpyogenic thrombosis of intracranial venous systemOther reaction to spinal and lumbar punctureOther specified headache syndromesBenign intracranial hypertensionDRKS00025278eurologie200
进行中(未招募)
1 期
The effect of erenumab on the headache inducing properties provocation triggers in migraine patientsMigraineEUCTR2020-000661-16-DKRigshospitalet Glostrup72
招募中
不适用
Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)Head PainMigraineNCT05785988Hospital Clínico Universitario de Valladolid600
